Bette Caan to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Bette Caan has written about Randomized Controlled Trials as Topic.
Connection Strength
1.065
-
Low energy reporting may increase in intervention participants enrolled in dietary intervention trials. J Am Diet Assoc. 2004 Mar; 104(3):357-66; quiz 491.
Score: 0.207
-
Lights on MsFLASH: a review of contributions. Menopause. 2020 04; 27(4):473-484.
Score: 0.158
-
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause. 2014 Jan; 21(1):45-58.
Score: 0.102
-
IGF1 and risk of additional breast cancer in the WHEL study. Endocr Relat Cancer. 2011 Apr; 18(2):235-44.
Score: 0.084
-
Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):854-8.
Score: 0.084
-
The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Ann Epidemiol. 2003 Oct; 13(9 Suppl):S87-97.
Score: 0.050
-
A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials. 2002 Dec; 23(6):728-56.
Score: 0.047
-
Does nutritionist review of a self-administered food frequency questionnaire improve data quality? Public Health Nutr. 1999 Dec; 2(4):565-9.
Score: 0.038
-
Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study. Int J Cancer. 2020 07 15; 147(2):404-412.
Score: 0.038
-
Facebook advertising for recruitment of midlife women with bothersome vaginal symptoms: A pilot study. Clin Trials. 2019 10; 16(5):476-480.
Score: 0.037
-
Reliability of plasma carotenoid biomarkers and its relation to study power. Epidemiology. 2008 Mar; 19(2):338-44.
Score: 0.034
-
The Women's Health Initiative (WHI) Life and Longevity After Cancer (LILAC) Study: Description and Baseline Characteristics of Participants. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):125-137.
Score: 0.034
-
Tamoxifen, hot flashes and recurrence in breast cancer. Breast Cancer Res Treat. 2008 Apr; 108(3):421-6.
Score: 0.032
-
The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics. Cancer Causes Control. 2011 Sep; 22(9):1319-31.
Score: 0.021
-
Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2008 Jun; 17(6):1344-53.
Score: 0.017
-
High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the polyp prevention trial. J Nutr. 2006 Jul; 136(7):1896-903.
Score: 0.015
-
Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. Am Heart J. 2006 Jul; 152(1):170-6.
Score: 0.015
-
Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Am J Epidemiol. 2006 Apr 01; 163(7):589-99.
Score: 0.015
-
Achieving substantial changes in eating behavior among women previously treated for breast cancer--an overview of the intervention. J Am Diet Assoc. 2005 Mar; 105(3):382-91; quiz 488.
Score: 0.014
-
Measuring dietary change in a diet intervention trial: comparing food frequency questionnaire and dietary recalls. Am J Epidemiol. 2003 Apr 15; 157(8):754-62.
Score: 0.012
-
Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group. J Am Diet Assoc. 1999 Oct; 99(10):1212-21.
Score: 0.010